Articles from Levi & Korsinsky

RDY shareholders saw Dr. Reddy’s Laboratories (NYSE: RDY) shares fall approximately 9% on July 22, 2026, after Q1 FY27 results included a ₹2.4 billion provision tied to out-of-spec semaglutide batches while FY27 margin commentary remained in focus. Investors who lost money on RDY after that provision disclosure are encouraged to act now. Levi & Korsinsky is investigating potential securities law violations involving Dr. Reddy’s forward-looking profitability statements. (212) 363-7500 | www.zlk.com

IBM (NYSE: IBM) shares fell nearly 25% on July 14, 2026, after the Company released preliminary second-quarter results that missed Wall Street expectations. Investors who held IBM through the earnings miss are reacting to a one-session loss tied directly to the Company’s reported results. Investors who lost money on IBM are encouraged to report your IBM losses today.

Shareholders of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) saw the stock plunged roughly 50% on June 1, 2026, following disclosure of an FDA safety concerns related to the PRC2 inhibitor drug class. Those who lost money on FULC are encouraged to submit their information immediately. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

Investors in Planet Fitness, Inc. (NYSE: PLNT) suffered significant losses after the Company issued weaker-than-expected FY 2026 outlook, undermining management’s earlier projection of approximately 9%-10% EPS growth discussed by CFO Jay Stasz during the Company’s Q4 2025 earnings call. Shareholders who lost money on their Planet Fitness investment are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.